Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares OutstandingShares Repurchased
Ratios

Genmab A (GMAB) Leases (2023 - 2025)

Historic Leases for Genmab A (GMAB) over the last 3 years, with Q4 2025 value amounting to $127.0 million.

  • Genmab A's Leases fell 78.12% to $127.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $127.0 million, marking a year-over-year decrease of 78.12%. This contributed to the annual value of $127.0 million for FY2025, which is 78.12% down from last year.
  • As of Q4 2025, Genmab A's Leases stood at $127.0 million, which was down 78.12% from $121.0 million recorded in Q3 2025.
  • In the past 5 years, Genmab A's Leases ranged from a high of $128.0 million in Q4 2024 and a low of $102.0 million during Q4 2023
  • Moreover, its 3-year median value for Leases was $125.5 million (2025), whereas its average is $121.5 million.
  • Its Leases has fluctuated over the past 5 years, first skyrocketed by 2549.02% in 2024, then plummeted by 78.12% in 2025.
  • Over the past 3 years, Genmab A's Leases (Quarter) stood at $102.0 million in 2023, then rose by 25.49% to $128.0 million in 2024, then fell by 0.78% to $127.0 million in 2025.
  • Its last three reported values are $127.0 million in Q4 2025, $121.0 million for Q3 2025, and $125.0 million during Q2 2025.